Khaled Tolba

Medicine · Health Sciences

19h-index2.0kcitations94works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(40), Cancer Genomics and Diagnostics(23), CAR-T cell therapy research(18), Virus-based gene therapy research(16), Cancer Immunotherapy and Biomarkers(11)

Publications93 total

Application of Electrolyzed Water as a Sustainable Technology for Food Safety in the Street Vending Sector and Environmental Conservation
Egyptian Journal of Veterinary Science·2026Open Access
Oxidized Water Vs. Other Disinfectants: A Comparative Study on the Risks Control of Food contact surfaces Contaminated with Escherichia coli and Salmonella
Egyptian Journal of Veterinary Science·2025Open Access
Analytical validation (accuracy, reproducibility, limit of detection) and gene expression analysis of FoundationOneRNA assay for fusion detection in 189 clinical tumor specimens
PLoS ONE·2025· 2 citedOpen Access
Antibacterial Efficacy of Chard and Arugula as Natural Nitrite Alternatives against Staphylococcus aureus, Listeria monocytogenes and Clostridium perfringens in Basterma
Egyptian Journal of Veterinary Science·2025Open Access
Data from Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non–Small Cell Lung Cancer: A Lung-MAP Study
2025Open Access
First-line pembrolizumab for metastatic NSCLC in lower-middle-income countries: bridging the efficacy-effectiveness gap
Immunotherapy·2025Open Access
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non–Small Cell Lung Cancer: A Lung-MAP Study
Clinical Cancer Research·2025Open Access
1352P Real-world second-line outcomes of NSCLC patients receiving first-line chemotherapy plus immunotherapy
Annals of Oncology·2024· 1 citedOpen Access
Lung-MAP Next-Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400)
Journal of Thoracic Oncology·2024· 5 citedOpen Access
Association of Timely Comprehensive Genomic Profiling With Precision Oncology Treatment Use and Patient Outcomes in Advanced Non–Small-Cell Lung Cancer
JCO Precision Oncology·2024· 6 citedOpen Access
Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC
The Oncologist·2024· 7 citedOpen Access
The effect of ctDNA tumor fraction (TF) on overall survival and concordance between tissue genomics and ctDNA in Lung-MAP.
Journal of Clinical Oncology·2023
SPARK, studying pathways of resistance in KRAS-driven cancers: A remote plasma ctDNA participation study to identify mechanisms of resistance to KRAS inhibitors.
Journal of Clinical Oncology·2023· 1 cited
Supplementary Figure 1 from Adoptively Transferred Tumor-Specific T Cells Stimulated <i>Ex vivo</i> Using Herpes Simplex Virus Amplicons Encoding 4-1BBL Persist in the Host and Show Antitumor Activity <i>In vivo</i>
2023Open Access
Supplementary Figure 2 Legend from Adoptively Transferred Tumor-Specific T Cells Stimulated <i>Ex vivo</i> Using Herpes Simplex Virus Amplicons Encoding 4-1BBL Persist in the Host and Show Antitumor Activity <i>In vivo</i>
2023Open Access
Supplementary Figure 2 from Adoptively Transferred Tumor-Specific T Cells Stimulated <i>Ex vivo</i> Using Herpes Simplex Virus Amplicons Encoding 4-1BBL Persist in the Host and Show Antitumor Activity <i>In vivo</i>
2023Open Access
Supplementary Figure 2 Legend from Adoptively Transferred Tumor-Specific T Cells Stimulated <i>Ex vivo</i> Using Herpes Simplex Virus Amplicons Encoding 4-1BBL Persist in the Host and Show Antitumor Activity <i>In vivo</i>
2023Open Access
Data from Adoptively Transferred Tumor-Specific T Cells Stimulated <i>Ex vivo</i> Using Herpes Simplex Virus Amplicons Encoding 4-1BBL Persist in the Host and Show Antitumor Activity <i>In vivo</i>
2023Open Access
Supplementary Figure 2 from Adoptively Transferred Tumor-Specific T Cells Stimulated <i>Ex vivo</i> Using Herpes Simplex Virus Amplicons Encoding 4-1BBL Persist in the Host and Show Antitumor Activity <i>In vivo</i>
2023Open Access
Supplementary Figure 1 Legend from Adoptively Transferred Tumor-Specific T Cells Stimulated <i>Ex vivo</i> Using Herpes Simplex Virus Amplicons Encoding 4-1BBL Persist in the Host and Show Antitumor Activity <i>In vivo</i>
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Geoffrey R. Oxnard(13), Alexa B. Schrock(10), Richard S.P. Huang(10), Joseph D. Rosenblatt(8), Janessa Laskin(6), Stephen V. Liu(6), Parneet Cheema(6), J. Cadranel(6), Martin Jones(6), A. Cseh(6), Flavio Solca(6), M. Duruisseaux(6), Howard J. Federoff(6), William J. Bowers(6), Christoph Heining(5), Richard F. Schlenk(5), Jeffrey S. Ross(5), Eva Brandén(5), Yasushi Goto(5), Domenico Trombetta(5)